Date | Debt to Equity Ratio | Debt to Income Ratio | Debt to Tangible Net Worth Ratio | Dividend Coverage Ratio |
---|
CEO | Mr. Richard Saynor |
IPO Date | Oct. 3, 2023 |
Location | Switzerland |
Headquarters | Suurstoffi 14 |
Employees | 22,633 |
Sector | Healthcare |
Industries |
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. It develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. The company was founded in 1886 and is headquartered in Rotkreuz, Switzerland.
Past 5 years
StockViz Staff
February 7, 2025
Any question? Send us an email